Insider Transactions in Q2 2021 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2021
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,142
-10.59%
|
$265,704
$12.07 P/Share
|
|
Jun 18
2021
|
Spencer Lee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,690
-21.53%
|
$164,280
$12.07 P/Share
|
|
Jun 18
2021
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,571
-4.03%
|
$114,852
$12.07 P/Share
|
|
Jun 18
2021
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,368
-10.01%
|
$16,416
$12.07 P/Share
|
|
Jun 18
2021
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,829
-1.0%
|
$45,948
$12.07 P/Share
|
|
Jun 16
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,209
+16.47%
|
-
|
|
Jun 16
2021
|
Spencer Lee Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,667
+28.76%
|
-
|
|
Jun 16
2021
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,340
+9.29%
|
-
|
|
Jun 16
2021
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,645
+29.24%
|
-
|
|
Jun 16
2021
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,086
+2.56%
|
-
|
|
Jun 16
2021
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
565
+14.29%
|
-
|
|
May 24
2021
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
196,553
-53.95%
|
$1,965,530
$10.56 P/Share
|
|
May 24
2021
|
Spencer Lee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
44,062
-53.75%
|
$440,620
$10.56 P/Share
|
|
May 24
2021
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
31,505
-12.87%
|
$315,050
$10.56 P/Share
|
|
May 24
2021
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,570
-24.27%
|
$25,700
$10.56 P/Share
|
|
May 24
2021
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,928
-0.78%
|
$29,280
$10.56 P/Share
|
|
May 20
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
364,339
+50.0%
|
-
|
|
May 20
2021
|
Spencer Lee Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
81,978
+50.0%
|
-
|
|
May 20
2021
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
104,271
+29.88%
|
-
|
|
May 20
2021
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,589
+50.0%
|
-
|
|
May 20
2021
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,473
+2.2%
|
-
|
|
May 20
2021
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,824
+50.0%
|
-
|
|
Apr 16
2021
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,000
+22.59%
|
$0
$0.4 P/Share
|